Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

PAD, AAA: High Lp(a) Portends Problems Beyond CVD

Caitlin E. Cox

December 06, 2023

News Daily News

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Michael O'Riordan

December 06, 2023

News Conference News AHA 2023

Large, Sustained Reductions in Lp(a) With Lepodisiran in Phase I Study

Michael O'Riordan

November 13, 2023

RNA-Interference Agent Zilebesiran Looks Promising for BP-Lowering KARDIA-1

News Conference News AHA 2023

RNA-Interference Agent Zilebesiran Looks Promising for BP: KARDIA-1

Caitlin E. Cox

November 11, 2023

News Conference News AHA 2023

Inflammation More Powerful Than LDL as CV Risk Predictor in Statin-Free Patients

Caitlin E. Cox

November 07, 2023

News Conference News HFSA 2023

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

L.A. McKeown

October 18, 2023

News Daily News

E-Cigarette Use on the Rise in US Adults With CVD

Caitlin E. Cox

August 16, 2023

News Conference News EAS 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Michael O'Riordan

May 29, 2023

News Conference News EAS 2023

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

Michael O'Riordan

May 24, 2023

News Daily News

AHA Urges Holistic Cardiovascular Care of Women, With Focus on Race/Ethnicity

Yael L. Maxwell

April 10, 2023

News Daily News

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

L.A. McKeown

March 29, 2023

News Daily News

AHA/ACC Scientific Statement Supports Exercise Therapy in HFpEF

L.A. McKeown

March 27, 2023

News Conference News ACC 2023

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Caitlin E. Cox

March 14, 2023

News Daily News

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Michael O'Riordan

January 20, 2023

News Daily News

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Michael O'Riordan

January 16, 2023

News Daily News

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Michael O'Riordan

January 05, 2023

News Daily News

Top Policy and Practice News for Cardiologists in 2022

Caitlin E. Cox

January 02, 2023

Advertisement

PAD, AAA: High Lp(a) Portends Problems Beyond CVD

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Large, Sustained Reductions in Lp(a) With Lepodisiran in Phase I Study

RNA-Interference Agent Zilebesiran Looks Promising for BP: KARDIA-1

Inflammation More Powerful Than LDL as CV Risk Predictor in Statin-Free Patients

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

E-Cigarette Use on the Rise in US Adults With CVD

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

AHA Urges Holistic Cardiovascular Care of Women, With Focus on Race/Ethnicity

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

AHA/ACC Scientific Statement Supports Exercise Therapy in HFpEF

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Top Policy and Practice News for Cardiologists in 2022

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content